NCT00054756View on ClinicalTrials.gov

Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 7, 2003

Primary Completion Date

September 26, 2014

Study Completion Date

September 26, 2014

Conditions

HealthyPituitary DiseaseThyroid Disease

Interventions

DRUG

TRH (Thyrotropin Releasing Hormone)

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00054756 - Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities | Biotech Hunter | Biotech Hunter